These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1441728)

  • 21. Persistence of vaccine-induced antibody to hepatitis A virus.
    Wiedermann G; Ambrosch F; André FE; D'Hondt E; Delem A; Safary A
    Vaccine; 1992; 10 Suppl 1():S129-31. PubMed ID: 1335643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis A vaccination by intracutaneous low dose administration: a less expensive alternative.
    Carlsson U; Brudin L; Eliasson I; Hansson BG
    Scand J Infect Dis; 1996; 28(5):435-8. PubMed ID: 8953668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.
    Sandman L; Davidson M; Krugman S
    J Infect Dis; 1995 Mar; 171 Suppl 1():S50-2. PubMed ID: 7876649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. National Advisory Committee on Immunization (NACI). Statement on the prevention of hepatitis A infections.
    Can Commun Dis Rep; 1994 Aug; 20(16):133-43. PubMed ID: 7951129
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatitis A vaccine.
    Med Lett Drugs Ther; 1995 Jun; 37(950):51-2. PubMed ID: 7760768
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of two immunization schedules with an inactivated hepatitis A vaccine (AvaximTM).
    Vidor E; Ratheau C; Briantais P; Vuillier D
    J Travel Med; 1998 Dec; 5(4):167-72. PubMed ID: 9876189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and safety in adults of hepatitis A virus vaccine administered as a single dose with a booster 6 months later.
    Briem H; Safary A
    J Med Virol; 1994 Dec; 44(4):443-5. PubMed ID: 7897378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of inactivated hepatitis A vaccine in children.
    Lee SD; Lo KJ; Chan CY; Yu MY; Wang YJ; Safary A
    Gastroenterology; 1993 Apr; 104(4):1129-32. PubMed ID: 8462802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children.
    Balcarek KB; Bagley MR; Pass RF; Schiff ER; Krause DS
    J Infect Dis; 1995 Mar; 171 Suppl 1():S70-2. PubMed ID: 7876652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reactivity and immunogenicity of Havrix 360 vaccine for hepatitis A].
    Borcić B; Kovac S; Mihaljević I; Dobrovsak-Sourek V; Ljubicić M
    Lijec Vjesn; 1996; 118(7-8):162-4. PubMed ID: 8965633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A.
    Ellerbeck EF; Lewis JA; Nalin D; Gershman K; Miller WJ; Armstrong ME; Davide JP; Rhoad AE; McGuire B; Calandra G
    Vaccine; 1992; 10(10):668-72. PubMed ID: 1523877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of immunogenicity and safety in healthy adults of an inactivated anti-hepatitis A vaccine].
    Gil A; González A; Dal-Ré ; Aguilar L; Malo C; del Rey J
    Med Clin (Barc); 1994 May; 102(20):769-71. PubMed ID: 8041214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose response study of an inactivated hepatitis A virus vaccine.
    Carlsson RM; Claesson BA; Iwarson SA
    J Hepatol; 1993; 18 Suppl 2():S41-5. PubMed ID: 8182272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivated hepatitis A vaccine in childhood: implications for disease control.
    Nalin D; Brown L; Kuter B; Patterson C; McGuire B; Werzberger A; Santosham M; Block S; Reisinger K; Watson B
    Vaccine; 1993; 11 Suppl 1():S15-7. PubMed ID: 8383388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination against hepatitis A: comparison of different short-term immunization schedules.
    Jilg W; Bittner R; Bock HL; Clemens R; Schätzl H; Schmidt M; André FE; Deinhardt F
    Vaccine; 1992; 10 Suppl 1():S126-8. PubMed ID: 1335642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization of US soldiers with a two-dose primary series of inactivated hepatitis A vaccine: early immune response, persistence of antibody, and response to a third dose at 1 year.
    DeFraites RF; Feighner BH; Binn LN; Kanjarpane DD; Delem AD; MacArthy PO; Krauss MR; Krause DS; Moonsammy GI; Hoke CH
    J Infect Dis; 1995 Mar; 171 Suppl 1():S61-9. PubMed ID: 7876651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis A vaccine: persistence of antibodies 5 years after the first vaccination.
    Totos G; Gizaris V; Papaevangelou G
    Vaccine; 1997 Aug; 15(11):1252-3. PubMed ID: 9286052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Administration of hepatitis A vaccine to a military population by needle and jet injector and with hepatitis B vaccine.
    Hoke CH; Egan JE; Sjogren MH; Sanchez J; DeFraites RF; MacArthy PO; Binn LN; Rice R; Burke A; Hill J
    J Infect Dis; 1995 Mar; 171 Suppl 1():S53-60. PubMed ID: 7876650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis A vaccines.
    Wkly Epidemiol Rec; 2000 Feb; 75(5):38-44. PubMed ID: 10693358
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccine.
    Maiwald H; Jilg W; Bock HL; Löscher T; Sonnenburg F
    Vaccine; 1997 Mar; 15(4):346-8. PubMed ID: 9141202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.